Multiple Sclerosis Severity Scale and whole-brain N-acetylaspartate concentration for patients’ assessment

Longitudinal Whole-BrainN-Acetylaspartate Concentration in Healthy Adults

(2011) D.J. Rigotti et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Axonal and neuronal pathology in multiple sclerosis: What have we learnt from animal models

(2009) Hans Lassmann   EXPERIMENTAL NEUROLOGY

The multiple sclerosis severity score (MSSS) predicts disease severity over time

(2009) Andrew R. Pachner et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

MRI features of benign multiple sclerosis: Toward a new definition of this disease phenotype

(2009) M. Rovaris et al.   NEUROLOGY

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

(2008) L. K. Fisniku et al.   BRAIN

Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis

(2008) C Hirst et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease

(2008) L Costelloe et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The Clinical Epidemiology of Multiple Sclerosis

(2008) Christian Confavreux et al.   NEUROIMAGING CLINICS OF NORTH AMERICA

N-Acetylaspartate and N-acetylaspartylglutamate: Neurobiology and clinical significance

(2008) E. E. Benarroch   NEUROLOGY

Cognitive impairment and structural brain damage in benign multiple sclerosis

(2008) M. Rovaris et al.   NEUROLOGY

The topographical distribution of tissue injury in benign MS: A 3T multiparametric MRI study

(2007) Antonia Ceccarelli et al.   NEUROIMAGE